Role of the BBB in HIV brain infection during methamphetamine abuse

Project: Research project

Description

DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) is the most prominent barrier of the CNS and represents the essential interface between the CNS and the blood stream. The intact BBB is maintained by tight junction (TJ) proteins and is a paramount determinant of brain homeostasis. Disruption of the BBB is frequently observed during drug abuse and brain infections by various pathogens, including HIV. Our critically important results indicate that occludin, one of the major TJ proteins, is decreased upon methamphetamine (METH) exposure and that diminished occludin levels not only lead to the loss of integrity of the BBB but also stimulate HIV replication. The proposed research is built on these exciting findings by its focus on the central hypothesis that cerebrovascular alterations at the BBB level induced by METH have profound impact on establishing and outcome of the brain infection by HIV. Guided by the preliminary findings, this application offers a unique perspective on the interactions between METH and HIV via targeting the BBB. In Aim 1, we will evaluate the impact of METH-induced decrease in occludin expression on activation of NF-?B and SP-1, enhancing interactions of this transcription factors with the HIV long-terminal repeats (LTRs) and thus stimulating HIV replication. In Aim 2, we will study the impact of METH and HIV-induced disruption of BBB on aberrant neurogenesis of neural progenitor cells resulting in the development of cognitive dysfunction. Aim 3 will focus on behavioral intervention based on exercise for protection against METH and HIV-induced BBB dysfunction and neurocognitive alterations. The proposed research is highly innovative and is likely to lead to the development of new translational knowledge for the clinic and identification of new regulatory mechanisms of HIV replication. The completion of this application has the potential to change our understanding of the cellular role of occludin in HIV infection and the role of the BBB in the development of METH and/or HIV-associated cognitive dysfunction. Furthermore, the expected results are likely to be also relevant to other neurodegenerative diseases that have significant cerebrovascular components.
StatusActive
Effective start/end date4/1/153/31/20

Funding

  • National Institutes of Health: $383,750.00
  • National Institutes of Health: $383,750.00
  • National Institutes of Health: $383,750.00
  • National Institutes of Health: $105,901.00
  • National Institutes of Health: $379,912.00
  • National Institutes of Health: $383,750.00

Fingerprint

Methamphetamine
Blood-Brain Barrier
HIV Infections
HIV
Occludin
Brain
Tight Junction Proteins
HIV Long Terminal Repeat
Neurogenesis
Research
Neurodegenerative Diseases
Substance-Related Disorders
Homeostasis
Transcription Factors
Stem Cells

ASJC

  • Medicine(all)